Ampio Pharmaceuticals, Inc.
(NYSE Amex Equities : AMPE)

( )
AMPE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
PTLAPortola Pharmaceuticals, Inc. 0.00%17.836.5%$152.32m
HZNPHorizon Therapeutics Plc 3.40%49.566.5%$134.76m
MYOKMyoKardia, Inc. 0.72%107.501.8%$127.14m
VRXValeant Pharmaceuticals International, Inc. -2.26%17.7714.1%$104.56m
CTLTCatalent, Inc. 0.37%78.592.3%$97.17m
AXSMAxsome Therapeutics, Inc. -2.48%80.901.9%$77.95m
UTHRUnited Therapeutics Corp. 0.32%117.5714.3%$75.31m
AMRNAmarin Corp. Plc -0.55%7.241.6%$72.93m
ICPTIntercept Pharmaceuticals, Inc. -12.19%80.5116.8%$57.24m
GWPHGW Pharmaceuticals Plc 1.33%126.926.2%$53.38m
JAZZJazz Pharmaceuticals Plc -1.14%109.592.4%$52.77m
PRGOPerrigo Co. Plc 0.00%54.336.8%$48.06m
ICLRICON plc 1.07%166.514.3%$47.57m
SAGESAGE Therapeutics, Inc. 2.53%38.948.6%$41.12m
MDGLMadrigal Pharmaceuticals, Inc. 5.33%125.710.3%$30.65m

Company Profile

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.